| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoblastoma Protein | 80 | 2023 | 670 | 11.420 |
Why?
|
| E2F Transcription Factors | 49 | 2023 | 270 | 4.970 |
Why?
|
| Drosophila Proteins | 38 | 2021 | 1705 | 4.760 |
Why?
|
| Drosophila melanogaster | 20 | 2014 | 1725 | 2.530 |
Why?
|
| E2F1 Transcription Factor | 20 | 2022 | 182 | 2.370 |
Why?
|
| Transcription Factors | 57 | 2023 | 12159 | 2.370 |
Why?
|
| Cell Cycle Proteins | 46 | 2023 | 3440 | 2.320 |
Why?
|
| Cell Cycle | 37 | 2023 | 2925 | 1.730 |
Why?
|
| Drosophila | 20 | 2021 | 1509 | 1.570 |
Why?
|
| DNA-Binding Proteins | 49 | 2017 | 9613 | 1.530 |
Why?
|
| Chromatin | 17 | 2023 | 2980 | 1.250 |
Why?
|
| Trans-Activators | 13 | 2017 | 2856 | 1.250 |
Why?
|
| Chromosomal Instability | 4 | 2014 | 176 | 1.170 |
Why?
|
| E2F2 Transcription Factor | 10 | 2014 | 35 | 1.090 |
Why?
|
| Carrier Proteins | 29 | 2004 | 4926 | 1.070 |
Why?
|
| Oncogene Proteins, Viral | 15 | 2006 | 342 | 1.010 |
Why?
|
| Histone Demethylases | 4 | 2015 | 328 | 0.960 |
Why?
|
| Fat Body | 3 | 2021 | 32 | 0.880 |
Why?
|
| Oxidoreductases, N-Demethylating | 4 | 2015 | 109 | 0.830 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 1885 | 0.810 |
Why?
|
| Retinoblastoma | 8 | 2021 | 321 | 0.780 |
Why?
|
| Gene Expression Regulation | 20 | 2015 | 11924 | 0.770 |
Why?
|
| S Phase | 16 | 2014 | 424 | 0.760 |
Why?
|
| Nuclear Proteins | 25 | 2014 | 5795 | 0.740 |
Why?
|
| Histones | 10 | 2014 | 2595 | 0.740 |
Why?
|
| Gene Expression Regulation, Neoplastic | 14 | 2021 | 8623 | 0.710 |
Why?
|
| Retinoblastoma Binding Proteins | 2 | 2021 | 101 | 0.690 |
Why?
|
| Repressor Proteins | 14 | 2011 | 2979 | 0.650 |
Why?
|
| Small Cell Lung Carcinoma | 5 | 2024 | 454 | 0.630 |
Why?
|
| Cyclin-Dependent Kinase 4 | 7 | 2019 | 562 | 0.630 |
Why?
|
| Chromosomal Proteins, Non-Histone | 5 | 2014 | 724 | 0.620 |
Why?
|
| Chromosome Structures | 1 | 2018 | 11 | 0.620 |
Why?
|
| Cyclin-Dependent Kinase 6 | 3 | 2019 | 352 | 0.620 |
Why?
|
| Gene Expression Regulation, Developmental | 12 | 2021 | 3610 | 0.600 |
Why?
|
| Transcription, Genetic | 18 | 2021 | 7612 | 0.600 |
Why?
|
| Adenosine Triphosphatases | 4 | 2012 | 840 | 0.590 |
Why?
|
| Apoptosis | 19 | 2019 | 9514 | 0.580 |
Why?
|
| Cyclin-Dependent Kinases | 8 | 2008 | 661 | 0.580 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 25 | 2000 | 138 | 0.580 |
Why?
|
| Animals | 104 | 2024 | 168939 | 0.570 |
Why?
|
| Histone Code | 1 | 2018 | 160 | 0.570 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 501 | 0.560 |
Why?
|
| Cell Proliferation | 12 | 2019 | 10451 | 0.550 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2014 | 385 | 0.550 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2014 | 2801 | 0.530 |
Why?
|
| Mitosis | 8 | 2013 | 1176 | 0.520 |
Why?
|
| Cell Division | 15 | 2023 | 4473 | 0.520 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2016 | 287 | 0.510 |
Why?
|
| DNA Replication | 13 | 2022 | 1426 | 0.490 |
Why?
|
| Centromere | 3 | 2014 | 214 | 0.490 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2015 | 393 | 0.490 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2014 | 705 | 0.490 |
Why?
|
| Methylation | 9 | 2014 | 1076 | 0.490 |
Why?
|
| Cell Nucleus | 4 | 2022 | 2875 | 0.480 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2016 | 781 | 0.470 |
Why?
|
| DNA Damage | 11 | 2022 | 2469 | 0.460 |
Why?
|
| Tumor Suppressor Protein p53 | 9 | 2013 | 2952 | 0.440 |
Why?
|
| Genes, Retinoblastoma | 9 | 2012 | 125 | 0.430 |
Why?
|
| Transcription Factor DP1 | 20 | 2003 | 136 | 0.430 |
Why?
|
| G1 Phase | 11 | 2009 | 403 | 0.420 |
Why?
|
| GTP Phosphohydrolases | 1 | 2016 | 525 | 0.420 |
Why?
|
| Protein Binding | 21 | 2024 | 9326 | 0.420 |
Why?
|
| Drug Resistance, Neoplasm | 6 | 2024 | 5330 | 0.420 |
Why?
|
| Signal Transduction | 13 | 2019 | 23618 | 0.410 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2013 | 699 | 0.410 |
Why?
|
| Cell Line, Tumor | 18 | 2022 | 17089 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2024 | 996 | 0.400 |
Why?
|
| Eye | 9 | 2011 | 711 | 0.390 |
Why?
|
| Metabolism | 1 | 2013 | 193 | 0.390 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2016 | 2841 | 0.390 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2021 | 1900 | 0.380 |
Why?
|
| Suppression, Genetic | 5 | 2006 | 190 | 0.380 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 3427 | 0.380 |
Why?
|
| Proteins | 10 | 2001 | 6002 | 0.370 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2023 | 857 | 0.370 |
Why?
|
| Phosphoproteins | 10 | 2001 | 2448 | 0.360 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1073 | 0.350 |
Why?
|
| RNA Interference | 9 | 2015 | 2829 | 0.350 |
Why?
|
| Neoplasms | 11 | 2018 | 22350 | 0.340 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 350 | 0.340 |
Why?
|
| Phenotype | 16 | 2022 | 16722 | 0.340 |
Why?
|
| Glutamine | 1 | 2013 | 575 | 0.330 |
Why?
|
| Mutation | 25 | 2023 | 30214 | 0.330 |
Why?
|
| Genomic Instability | 6 | 2023 | 716 | 0.330 |
Why?
|
| Intestine, Small | 1 | 2015 | 1217 | 0.320 |
Why?
|
| Animals, Genetically Modified | 8 | 2014 | 1562 | 0.310 |
Why?
|
| Papillomaviridae | 6 | 2005 | 1139 | 0.310 |
Why?
|
| E2F7 Transcription Factor | 1 | 2008 | 2 | 0.300 |
Why?
|
| Phosphorylation | 10 | 2019 | 8310 | 0.300 |
Why?
|
| Blotting, Western | 8 | 2016 | 5022 | 0.280 |
Why?
|
| Retinoblastoma-Like Protein p107 | 11 | 2001 | 70 | 0.280 |
Why?
|
| Larva | 4 | 2013 | 511 | 0.270 |
Why?
|
| Anaphase | 1 | 2006 | 112 | 0.270 |
Why?
|
| Chromosome Segregation | 3 | 2014 | 230 | 0.270 |
Why?
|
| Histone Deacetylases | 5 | 2022 | 712 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2001 | 4523 | 0.260 |
Why?
|
| Cell Survival | 7 | 2017 | 5749 | 0.260 |
Why?
|
| Embryonic Structures | 1 | 2005 | 10 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2006 | 170 | 0.250 |
Why?
|
| Gene Silencing | 3 | 2016 | 1505 | 0.250 |
Why?
|
| Multiprotein Complexes | 2 | 2010 | 1110 | 0.250 |
Why?
|
| Molecular Sequence Data | 27 | 2006 | 17609 | 0.240 |
Why?
|
| Mitochondria | 3 | 2015 | 3678 | 0.230 |
Why?
|
| Embryonic Development | 2 | 2008 | 722 | 0.230 |
Why?
|
| Binding Sites | 12 | 2014 | 6013 | 0.230 |
Why?
|
| Epithelial Cells | 2 | 2016 | 3698 | 0.230 |
Why?
|
| Cyclins | 5 | 2000 | 605 | 0.220 |
Why?
|
| Amino Acid Sequence | 22 | 2006 | 13411 | 0.220 |
Why?
|
| Cells, Cultured | 16 | 2015 | 18986 | 0.220 |
Why?
|
| Antigens, Polyomavirus Transforming | 5 | 2009 | 256 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 8 | 2024 | 3605 | 0.220 |
Why?
|
| Cell Line | 12 | 2022 | 15564 | 0.220 |
Why?
|
| Adenovirus E1A Proteins | 4 | 2005 | 81 | 0.220 |
Why?
|
| DNA | 10 | 2022 | 7210 | 0.220 |
Why?
|
| beta Catenin | 1 | 2008 | 1048 | 0.210 |
Why?
|
| Gene Deletion | 5 | 2014 | 2669 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 4 | 2023 | 2823 | 0.210 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 111 | 0.210 |
Why?
|
| Lung Neoplasms | 7 | 2024 | 13489 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 8 | 2022 | 5795 | 0.200 |
Why?
|
| Humans | 86 | 2024 | 766812 | 0.200 |
Why?
|
| Mice | 39 | 2024 | 81898 | 0.200 |
Why?
|
| Insect Proteins | 2 | 2000 | 253 | 0.200 |
Why?
|
| Cell Transformation, Viral | 5 | 2006 | 527 | 0.200 |
Why?
|
| Cyclin E | 5 | 2006 | 155 | 0.200 |
Why?
|
| Receptors, Notch | 3 | 2011 | 751 | 0.200 |
Why?
|
| Nucleotidyltransferases | 1 | 2024 | 242 | 0.200 |
Why?
|
| Alleles | 7 | 2012 | 6896 | 0.200 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2003 | 301 | 0.190 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2016 | 3796 | 0.190 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2022 | 108 | 0.190 |
Why?
|
| Cytidine Deaminase | 1 | 2023 | 249 | 0.190 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 1150 | 0.190 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2013 | 168 | 0.180 |
Why?
|
| Genes, Insect | 2 | 1999 | 265 | 0.180 |
Why?
|
| Transfection | 8 | 2016 | 5755 | 0.180 |
Why?
|
| Autophagy | 2 | 2022 | 1345 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 3 | 2019 | 5444 | 0.180 |
Why?
|
| Models, Biological | 7 | 2013 | 9464 | 0.180 |
Why?
|
| In Situ Hybridization | 4 | 2012 | 1892 | 0.180 |
Why?
|
| Nucleotides | 2 | 2013 | 454 | 0.180 |
Why?
|
| HeLa Cells | 7 | 2015 | 3073 | 0.180 |
Why?
|
| Retinoblastoma-Like Protein p130 | 5 | 2001 | 72 | 0.170 |
Why?
|
| Arabidopsis Proteins | 1 | 2002 | 261 | 0.170 |
Why?
|
| Molecular Chaperones | 1 | 2004 | 760 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 10 | 2019 | 6105 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3079 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7869 | 0.170 |
Why?
|
| Gene Amplification | 1 | 2024 | 1088 | 0.160 |
Why?
|
| Microscopy, Electron, Scanning | 4 | 2005 | 939 | 0.160 |
Why?
|
| Aspergillus nidulans | 2 | 1989 | 8 | 0.160 |
Why?
|
| Retinal Neoplasms | 1 | 2021 | 151 | 0.160 |
Why?
|
| Sirtuin 1 | 2 | 2011 | 247 | 0.160 |
Why?
|
| DNA Repair | 4 | 2018 | 2050 | 0.160 |
Why?
|
| Polyomavirus | 2 | 1990 | 236 | 0.160 |
Why?
|
| Cullin Proteins | 2 | 2010 | 180 | 0.160 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2016 | 1057 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 741 | 0.150 |
Why?
|
| DNA Methylation | 2 | 2016 | 4427 | 0.150 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2019 | 172 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 4570 | 0.150 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 116 | 0.150 |
Why?
|
| Cyclin D3 | 1 | 2017 | 54 | 0.140 |
Why?
|
| Multigene Family | 2 | 2012 | 1081 | 0.140 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2021 | 343 | 0.140 |
Why?
|
| Genome | 3 | 2023 | 1753 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2019 | 1117 | 0.140 |
Why?
|
| Proliferating Cell Nuclear Antigen | 5 | 2010 | 284 | 0.140 |
Why?
|
| Oncogenes | 3 | 1999 | 1232 | 0.140 |
Why?
|
| Stress, Physiological | 2 | 2015 | 1407 | 0.140 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 946 | 0.130 |
Why?
|
| Blotting, Northern | 4 | 2005 | 1550 | 0.130 |
Why?
|
| Heterochromatin | 2 | 2011 | 294 | 0.130 |
Why?
|
| Serine | 2 | 2017 | 828 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2012 | 3789 | 0.130 |
Why?
|
| Proteomics | 3 | 2021 | 3915 | 0.130 |
Why?
|
| Polyadenylation | 1 | 2016 | 114 | 0.130 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 21162 | 0.120 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 183 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2010 | 632 | 0.120 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 3828 | 0.120 |
Why?
|
| Fasting | 2 | 2013 | 1609 | 0.120 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 904 | 0.120 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2014 | 20 | 0.120 |
Why?
|
| Transcriptional Activation | 9 | 2002 | 1751 | 0.120 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2014 | 56 | 0.120 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 2 | 2015 | 135 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2014 | 102 | 0.110 |
Why?
|
| MyoD Protein | 1 | 2014 | 143 | 0.110 |
Why?
|
| Lipogenesis | 1 | 2015 | 217 | 0.110 |
Why?
|
| Papillomavirus E7 Proteins | 5 | 2006 | 109 | 0.110 |
Why?
|
| Neuropeptides | 2 | 2012 | 950 | 0.110 |
Why?
|
| Adenovirus Early Proteins | 7 | 1992 | 58 | 0.110 |
Why?
|
| Cadherins | 2 | 2009 | 903 | 0.110 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 481 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 1999 | 2746 | 0.100 |
Why?
|
| Origin Recognition Complex | 1 | 2012 | 20 | 0.100 |
Why?
|
| Ubiquitin | 2 | 2008 | 841 | 0.100 |
Why?
|
| Testis | 1 | 1996 | 786 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 804 | 0.100 |
Why?
|
| HCT116 Cells | 1 | 2013 | 403 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2002 | 2882 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 230 | 0.100 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2011 | 39 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 2 | 2013 | 1604 | 0.100 |
Why?
|
| RNA, Fungal | 2 | 1989 | 156 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2021 | 1144 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2010 | 1965 | 0.090 |
Why?
|
| Eye Neoplasms | 3 | 1990 | 305 | 0.090 |
Why?
|
| Adenoviruses, Human | 1 | 1992 | 257 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2014 | 628 | 0.090 |
Why?
|
| Lysine | 2 | 2013 | 998 | 0.090 |
Why?
|
| Mice, Knockout | 10 | 2008 | 14473 | 0.090 |
Why?
|
| Cell Differentiation | 7 | 2006 | 11657 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3667 | 0.090 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2011 | 183 | 0.090 |
Why?
|
| Glutathione | 1 | 2013 | 589 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2010 | 58 | 0.090 |
Why?
|
| Base Sequence | 13 | 1996 | 12415 | 0.090 |
Why?
|
| Drug Synergism | 1 | 2014 | 1757 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2001 | 1405 | 0.080 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 515 | 0.080 |
Why?
|
| Lysosomes | 1 | 2015 | 937 | 0.080 |
Why?
|
| Glioma | 2 | 2002 | 3498 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 3 | 2013 | 3759 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 980 | 0.080 |
Why?
|
| DNA Tumor Viruses | 1 | 1989 | 4 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 3610 | 0.080 |
Why?
|
| Genomics | 2 | 2018 | 5922 | 0.080 |
Why?
|
| JC Virus | 1 | 1989 | 87 | 0.080 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1989 | 153 | 0.080 |
Why?
|
| Embryo, Nonmammalian | 3 | 2005 | 910 | 0.080 |
Why?
|
| Simian virus 40 | 1 | 1989 | 291 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 2060 | 0.080 |
Why?
|
| Gene Dosage | 1 | 2013 | 1211 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2470 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2002 | 1677 | 0.080 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 663 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2008 | 49 | 0.080 |
Why?
|
| Neurons | 4 | 2001 | 9515 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11876 | 0.080 |
Why?
|
| Stem Cell Factor | 1 | 2008 | 194 | 0.080 |
Why?
|
| Glycolysis | 3 | 2017 | 837 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2019 | 1757 | 0.070 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 138 | 0.070 |
Why?
|
| Phthalazines | 2 | 2022 | 397 | 0.070 |
Why?
|
| Genes, Reporter | 2 | 2005 | 1525 | 0.070 |
Why?
|
| Mice, Mutant Strains | 6 | 2006 | 1751 | 0.070 |
Why?
|
| Immunoblotting | 1 | 2011 | 1647 | 0.070 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2008 | 182 | 0.070 |
Why?
|
| Research | 1 | 2016 | 1977 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 1996 | 1989 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2014 | 1366 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2012 | 2426 | 0.070 |
Why?
|
| Colon | 1 | 2015 | 1797 | 0.070 |
Why?
|
| Genes, Dominant | 2 | 2000 | 855 | 0.070 |
Why?
|
| Genes, myc | 1 | 2008 | 391 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2002 | 2177 | 0.070 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 2221 | 0.070 |
Why?
|
| Organ Specificity | 1 | 2012 | 1968 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 2510 | 0.070 |
Why?
|
| Aneuploidy | 2 | 2012 | 573 | 0.070 |
Why?
|
| Models, Genetic | 3 | 2005 | 3446 | 0.070 |
Why?
|
| Genetic Complementation Test | 2 | 1999 | 556 | 0.070 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2006 | 89 | 0.070 |
Why?
|
| Glioblastoma | 1 | 2002 | 3458 | 0.070 |
Why?
|
| Cell Death | 3 | 2012 | 1676 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 414 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 2887 | 0.070 |
Why?
|
| Female | 20 | 2019 | 396532 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2012 | 1526 | 0.070 |
Why?
|
| Down-Regulation | 2 | 2010 | 2931 | 0.070 |
Why?
|
| Crosses, Genetic | 2 | 2005 | 751 | 0.060 |
Why?
|
| Enzyme Inhibitors | 4 | 2019 | 3723 | 0.060 |
Why?
|
| Fibroblasts | 5 | 2013 | 4166 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 317 | 0.060 |
Why?
|
| RNA, Messenger | 6 | 2015 | 12795 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18329 | 0.060 |
Why?
|
| Neoplasm Proteins | 3 | 2002 | 3600 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2017 | 3139 | 0.060 |
Why?
|
| Precipitin Tests | 3 | 2003 | 816 | 0.060 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2004 | 3 | 0.060 |
Why?
|
| Retinoblastoma-Binding Protein 4 | 1 | 2004 | 12 | 0.060 |
Why?
|
| Purines | 2 | 2019 | 615 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 4 | 1990 | 1057 | 0.060 |
Why?
|
| Human papillomavirus 16 | 1 | 2006 | 268 | 0.060 |
Why?
|
| Aminopyridines | 2 | 2019 | 577 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2011 | 5890 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 722 | 0.060 |
Why?
|
| Homozygote | 3 | 2005 | 1775 | 0.060 |
Why?
|
| Conserved Sequence | 2 | 2000 | 1159 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2012 | 1276 | 0.060 |
Why?
|
| Binding, Competitive | 4 | 1992 | 1141 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2012 | 1429 | 0.060 |
Why?
|
| Transgenes | 2 | 2005 | 1014 | 0.060 |
Why?
|
| RNA Splicing | 1 | 1988 | 903 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2004 | 230 | 0.050 |
Why?
|
| Enzyme Activation | 3 | 2009 | 3587 | 0.050 |
Why?
|
| Organisms, Genetically Modified | 1 | 2002 | 63 | 0.050 |
Why?
|
| Amino Acid Motifs | 2 | 2002 | 928 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 185 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6066 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1657 | 0.050 |
Why?
|
| Growth Inhibitors | 2 | 1994 | 375 | 0.050 |
Why?
|
| Tyrphostins | 1 | 2002 | 62 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2009 | 1610 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2004 | 333 | 0.050 |
Why?
|
| Glycoproteins | 1 | 2009 | 2201 | 0.050 |
Why?
|
| Chromosomes | 1 | 2005 | 578 | 0.050 |
Why?
|
| Cyclin D1 | 2 | 2001 | 453 | 0.050 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2001 | 1836 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2002 | 185 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2002 | 203 | 0.050 |
Why?
|
| Glucose | 1 | 2013 | 4340 | 0.050 |
Why?
|
| Trophoblasts | 1 | 2003 | 223 | 0.050 |
Why?
|
| Gene Expression | 4 | 1998 | 7585 | 0.050 |
Why?
|
| Luciferases | 1 | 2003 | 713 | 0.050 |
Why?
|
| Fetal Death | 1 | 2003 | 434 | 0.050 |
Why?
|
| Trehalose | 1 | 2021 | 88 | 0.050 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2024 | 481 | 0.050 |
Why?
|
| Ovary | 1 | 2005 | 963 | 0.050 |
Why?
|
| Transcription Factor AP-1 | 1 | 2022 | 321 | 0.050 |
Why?
|
| Genome, Human | 1 | 2014 | 4443 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2629 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4892 | 0.040 |
Why?
|
| Caspases | 2 | 2001 | 881 | 0.040 |
Why?
|
| Cyclin D | 1 | 2000 | 71 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 261 | 0.040 |
Why?
|
| DCMP Deaminase | 1 | 2019 | 7 | 0.040 |
Why?
|
| Piperazines | 2 | 2022 | 2547 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2002 | 200 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 13644 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2024 | 1882 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2004 | 777 | 0.040 |
Why?
|
| Plant Proteins | 1 | 2002 | 376 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2001 | 415 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2008 | 2573 | 0.040 |
Why?
|
| Genes, cdc | 1 | 1999 | 113 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2002 | 534 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2000 | 365 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11062 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 11094 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 2902 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 3053 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 605 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2015 | 432 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1999 | 189 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 329 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2006 | 2039 | 0.040 |
Why?
|
| E2F3 Transcription Factor | 2 | 1994 | 36 | 0.040 |
Why?
|
| Yeasts | 1 | 1999 | 278 | 0.040 |
Why?
|
| Dimerization | 1 | 1999 | 882 | 0.040 |
Why?
|
| Protein Stability | 2 | 2010 | 578 | 0.040 |
Why?
|
| Gene Targeting | 4 | 2006 | 841 | 0.040 |
Why?
|
| Liver Regeneration | 1 | 1999 | 213 | 0.040 |
Why?
|
| Phosphofructokinase-1 | 1 | 2017 | 51 | 0.040 |
Why?
|
| Reactive Nitrogen Species | 1 | 2017 | 35 | 0.040 |
Why?
|
| Culture Media, Serum-Free | 1 | 1997 | 147 | 0.040 |
Why?
|
| Nervous System | 1 | 2000 | 542 | 0.040 |
Why?
|
| Lens, Crystalline | 1 | 1999 | 387 | 0.040 |
Why?
|
| Gamma Rays | 1 | 1998 | 324 | 0.030 |
Why?
|
| Vinblastine | 1 | 1998 | 482 | 0.030 |
Why?
|
| Male | 10 | 2021 | 364154 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2017 | 126 | 0.030 |
Why?
|
| Retinal Dysplasia | 1 | 1996 | 12 | 0.030 |
Why?
|
| Lung | 1 | 2015 | 10068 | 0.030 |
Why?
|
| Exocrine Glands | 1 | 1996 | 46 | 0.030 |
Why?
|
| Muscles | 1 | 2021 | 1576 | 0.030 |
Why?
|
| Cloning, Molecular | 4 | 1994 | 4168 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1996 | 116 | 0.030 |
Why?
|
| Telomerase | 1 | 2001 | 750 | 0.030 |
Why?
|
| Vincristine | 1 | 1998 | 1040 | 0.030 |
Why?
|
| Transaminases | 1 | 2016 | 198 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2001 | 1675 | 0.030 |
Why?
|
| Retroelements | 1 | 2016 | 162 | 0.030 |
Why?
|
| Pyruvate Kinase | 1 | 2017 | 192 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 5690 | 0.030 |
Why?
|
| Quinazolines | 1 | 2002 | 1367 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2016 | 219 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 8 | 2015 | 22351 | 0.030 |
Why?
|
| Chimera | 1 | 1996 | 454 | 0.030 |
Why?
|
| Phylogeny | 1 | 2002 | 2840 | 0.030 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 330 | 0.030 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 1998 | 617 | 0.030 |
Why?
|
| Papillomavirus Infections | 1 | 2006 | 1639 | 0.030 |
Why?
|
| Biphenyl Compounds | 1 | 2019 | 1026 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 416 | 0.030 |
Why?
|
| Response Elements | 1 | 2015 | 308 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1836 | 0.030 |
Why?
|
| Time Factors | 2 | 2012 | 40149 | 0.030 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 384 | 0.030 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2015 | 257 | 0.030 |
Why?
|
| Glycine | 1 | 2016 | 670 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 594 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 3618 | 0.030 |
Why?
|
| Fetus | 1 | 2000 | 1878 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2626 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 326 | 0.030 |
Why?
|
| Peptide Mapping | 1 | 1992 | 259 | 0.030 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1996 | 527 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1996 | 715 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1992 | 174 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 10745 | 0.020 |
Why?
|
| Metabolomics | 1 | 2021 | 1674 | 0.020 |
Why?
|
| Cell Nucleolus | 2 | 2004 | 156 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1494 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1993 | 826 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2429 | 0.020 |
Why?
|
| Viral Proteins | 2 | 1996 | 1801 | 0.020 |
Why?
|
| Plasmids | 2 | 1994 | 2268 | 0.020 |
Why?
|
| Prognosis | 3 | 2019 | 29959 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 2012 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 1524 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2019 | 2252 | 0.020 |
Why?
|
| Caenorhabditis elegans | 2 | 2010 | 1474 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14653 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2013 | 640 | 0.020 |
Why?
|
| Atrophy | 1 | 1996 | 1631 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 4050 | 0.020 |
Why?
|
| Extremities | 1 | 1996 | 869 | 0.020 |
Why?
|
| Naphthols | 1 | 2010 | 46 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2019 | 10101 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 2 | 2001 | 133 | 0.020 |
Why?
|
| Mice, Transgenic | 4 | 2006 | 9546 | 0.020 |
Why?
|
| Receptors, Invertebrate Peptide | 1 | 2009 | 13 | 0.020 |
Why?
|
| Longevity | 1 | 1998 | 1083 | 0.020 |
Why?
|
| DNA Viruses | 1 | 1990 | 32 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2001 | 281 | 0.020 |
Why?
|
| Lymphoma, B-Cell | 1 | 1996 | 945 | 0.020 |
Why?
|
| Haplorhini | 1 | 1990 | 520 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 2144 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 1646 | 0.020 |
Why?
|
| Amino Acids | 1 | 2015 | 1711 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2002 | 9101 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1996 | 1374 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 874 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1762 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 710 | 0.020 |
Why?
|
| Caspase 3 | 2 | 2001 | 730 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1989 | 275 | 0.020 |
Why?
|
| Papio | 1 | 1990 | 672 | 0.020 |
Why?
|
| Niacinamide | 1 | 2010 | 419 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 1989 | 861 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1989 | 441 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 1055 | 0.020 |
Why?
|
| Sirtuins | 1 | 2010 | 322 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2019 | 3043 | 0.020 |
Why?
|
| Retroviridae | 1 | 1990 | 846 | 0.020 |
Why?
|
| Computational Biology | 1 | 2019 | 3564 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 1988 | 227 | 0.020 |
Why?
|
| Lymphoma | 1 | 1996 | 1899 | 0.020 |
Why?
|
| Epithelium | 1 | 2011 | 1606 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 4114 | 0.020 |
Why?
|
| Homeostasis | 2 | 2015 | 3343 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2000 | 3886 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6779 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 1007 | 0.020 |
Why?
|
| Rabbits | 1 | 1992 | 4752 | 0.020 |
Why?
|
| Protein Biosynthesis | 2 | 1990 | 2093 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1992 | 2201 | 0.010 |
Why?
|
| Benzamides | 1 | 2010 | 1375 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2005 | 376 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 4780 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2903 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4277 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 5753 | 0.010 |
Why?
|
| Virus Replication | 1 | 1992 | 2457 | 0.010 |
Why?
|
| DNA Polymerase III | 1 | 2004 | 52 | 0.010 |
Why?
|
| Peptides | 2 | 1992 | 4347 | 0.010 |
Why?
|
| Liver | 2 | 2015 | 7571 | 0.010 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2015 | 2186 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2006 | 391 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 2003 | 224 | 0.010 |
Why?
|
| Disease Progression | 1 | 2019 | 13642 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2005 | 1150 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 6359 | 0.010 |
Why?
|
| Chromatin Assembly Factor-1 | 1 | 2001 | 21 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 123 | 0.010 |
Why?
|
| Replication Protein C | 1 | 2001 | 26 | 0.010 |
Why?
|
| Hydro-Lyases | 1 | 2001 | 93 | 0.010 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2005 | 488 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2904 | 0.010 |
Why?
|
| Lamins | 1 | 2000 | 37 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 9407 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 420 | 0.010 |
Why?
|
| Middle Aged | 3 | 2019 | 223267 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2000 | 529 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 1999 | 33 | 0.010 |
Why?
|
| Coumarins | 1 | 2000 | 119 | 0.010 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2001 | 303 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 1826 | 0.010 |
Why?
|
| Estrogens | 1 | 2006 | 1528 | 0.010 |
Why?
|
| Lamin Type A | 1 | 2000 | 186 | 0.010 |
Why?
|
| Lipids | 1 | 2010 | 3322 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 1135 | 0.010 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 1999 | 133 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 1082 | 0.010 |
Why?
|
| Glutathione Transferase | 2 | 1991 | 565 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2009 | 4033 | 0.010 |
Why?
|
| CDC2 Protein Kinase | 1 | 1999 | 212 | 0.010 |
Why?
|
| Brain | 2 | 2011 | 27158 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 26309 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 915 | 0.010 |
Why?
|
| Camptothecin | 1 | 2001 | 599 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2001 | 901 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 1228 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 9244 | 0.010 |
Why?
|
| Aged | 2 | 2019 | 171344 | 0.010 |
Why?
|
| Rats | 2 | 1991 | 23717 | 0.010 |
Why?
|
| Stem Cells | 2 | 2001 | 3536 | 0.010 |
Why?
|
| Kinetics | 2 | 1996 | 6288 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1998 | 711 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2001 | 1100 | 0.010 |
Why?
|
| Hepatectomy | 1 | 1999 | 589 | 0.010 |
Why?
|
| DNA Helicases | 1 | 2001 | 854 | 0.010 |
Why?
|
| Body Weight | 2 | 1996 | 4626 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 1767 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 6507 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2000 | 1195 | 0.010 |
Why?
|
| Growth Plate | 1 | 1996 | 275 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20710 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1996 | 393 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59548 | 0.010 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 1993 | 35 | 0.010 |
Why?
|
| Adenovirus E2 Proteins | 1 | 1993 | 8 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1999 | 2677 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 1431 | 0.010 |
Why?
|
| Hemagglutinins | 1 | 1994 | 111 | 0.010 |
Why?
|
| Species Specificity | 1 | 1998 | 2413 | 0.010 |
Why?
|
| Germinal Center | 1 | 1996 | 379 | 0.010 |
Why?
|
| Bone Development | 1 | 1996 | 470 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 65286 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1991 | 3738 | 0.010 |
Why?
|
| Cartilage | 1 | 1996 | 811 | 0.010 |
Why?
|
| Heterozygote | 1 | 1998 | 2795 | 0.010 |
Why?
|
| Protein Multimerization | 1 | 1996 | 961 | 0.010 |
Why?
|
| Mammals | 1 | 1996 | 1133 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2678 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 1996 | 908 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 455 | 0.010 |
Why?
|
| Pituitary Neoplasms | 1 | 1998 | 1324 | 0.010 |
Why?
|
| DNA Primers | 1 | 1993 | 2826 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1996 | 1345 | 0.000 |
Why?
|
| Actins | 1 | 1996 | 2061 | 0.000 |
Why?
|
| Adult | 2 | 2019 | 223305 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1998 | 2671 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1998 | 4424 | 0.000 |
Why?
|
| Adenoviridae | 1 | 1990 | 1093 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1993 | 4618 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2660 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1990 | 1384 | 0.000 |
Why?
|
| Keratinocytes | 1 | 1989 | 876 | 0.000 |
Why?
|
| Thyroid Neoplasms | 1 | 1998 | 2355 | 0.000 |
Why?
|
| Bone Neoplasms | 1 | 1996 | 2561 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4968 | 0.000 |
Why?
|
| Pregnancy | 1 | 1999 | 30236 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2002 | 54872 | 0.000 |
Why?
|